Journals / Haseki Tıp Bülteni / 2017 / Cilt: 55 - Sayı: 2

Prevalence of Metabolic Syndrome in Primary Hyperparathyroidism

Primer Hiperparatiroidili Hastalarda Metabolik Sendrom Sıklığı

Pages
131–136
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, in these patients higher prevalence of hypertension, increased waist circumference, lipid disorders such as some syndrome abnormalities that may lead to the increased cardiovascular morbidity and mortality were observed

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Conclusion:­ In our study, the prevalence of MetS in patients with primary hyperparathyroidism was found to be similar to that demonstrated in epidemiological studies performed in the general population of the same age.
📊
Key Findings & Data:Conclusion:­ In our study, the prevalence of MetS in patients with primary hyperparathyroidism was found to be similar to that demonstrated in epidemiological studies performed in the general population of the same age.
💡
Conclusion & Impact:However, in these patients higher prevalence of hypertension, increased waist circumference, lipid disorders such as some syndrome abnormalities that may lead to the increased cardiovascular morbidity and mortality were observed
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Conclusion:­ In our study, the prevalence of MetS in patients with primary hyperparathyroidism was found to be similar to that demonstrated in epidemiological studies performed in the general population of the same age. However, in these patients higher prevalence of hypertension, increased waist circumference, lipid disorders such as some syndrome abnormalities that may lead to the increased cardiovascular morbidity and mortality were observed

Özet

Amaç: Çalışmamızda primer hiperparatiroidizm olgularında metabolik sendromun (MetS) sıklığının tespiti, metabolik sendrom parametrelerinin incelenmesi ve primer hiperparatiroidizmde MetS belirleyicilerinin tayini ile bu hastaların uzun dönem takibine ve yönetimine katkıda bulunmayı hedefledik.Yöntemler:­Kliniğimizde Ocak 2005 ile Aralık 2014 tarihleri arasında takip edilen, primer hiperparatioidizm olarak tanımlanan, 18 yaşını doldurmuş, gebe olmayan, böbrek ve karaciğer yetmezliği ve diğer sistemik hastalıkları olmayan 78 hasta çalışmaya dahil edildi. Bulgular: Hastaların 62'si (%79,5) kadın, 16'sı (%20,5) erkek, K/E: 3,87, yaş ortalamaları 55,3±12,6 yıl olarak saptandı. Hastalardan 58 tanesinin primer hiperparatiroidizme ait semptom taşıdığı, 20 tanesinin semptomatik olmadığı tespit edildi. Hastalar "National Cholesterol Education Program-Adult Treatment Panel III" metabolik sendrom tanı kriterlerine göre değerlendirildiğinde, 32 hastada (%41) MetS tespit edildi. MetS'li primer hiperparatiroidi hastalarında üriner sisteme ait taş hastalığı sıklığı, MetS olmayanlara göre istatiksel olarak anlamlı düzeyde yüksek tespit edildi (p=0,018). Sonuç: Çalışma grubumuzdaki primer hiperparatiroidizmli hastalarda metabolik sendrom sıklığının epidemiyolojik çalışmalardaki genel toplumun aynı yaş grubu bireylerindeki metabolik sendrom sıklığı ile benzer olduğu görüldü. Ancak bu hastalarda kardiyovasküler morbidite ve mortalite artışına neden olabilecek hipertansiyon, artmış bel çevresi, lipid profili bozukluğu gibi sendrom anormallikleri sıklıklarında artış olduğu saptandı.

🔖

Cite This Article

ÇEVİK, G. T., GÜLDİKEN, S., ATİLE, N. S., ÇELİK, H., ÇELİK, M., SALT, S. A., SÜT, N., TUĞRUL, A. A. (2017). Prevalence of Metabolic Syndrome in Primary Hyperparathyroidism. Haseki Tıp Bülteni, Cilt: 55 - Sayı: 2, 131–136. https://ajindex.com/articles/202327

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Tassone F, Gianotti L, Baffoni C, et al. Prevalence and characteristics of metabolic syndrome in primary hyperparathyroidism. J Endocrinol Invest 2012;35:841-6
  2. Khan AA, Bilezikian JP, Potts JT Jr. Guest Editors for the Third International Workshop on Asymptomatic Primary Hyperparathyroidism. The diagnosis and management of asymptomatic primary hyperparathyroidism revisited. J Clin Endocrinol Metab 2009;94:333-4
  3. Mendoza-Zubieta V, Gonzalez-Villaseior GA, Vargas-Ortega G, et al. High prevalence of metabolic syndrome in a group of adult patients with primary hyperparathyroidism (PHPT). BMC Endocr Disord 2015;15:16
  4. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2014;37:14-80
  5. Whitworth JA. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO) / International Society of Hypertension (ISH) statement on management of hypertension. J Hypertension 2003;21:1983-92
  6. Levesque J, Lamarche B. The metabolic syndrome: definitions, prevalence and management. J Nutrigenet Nutrigenomics 2008;1:100-8
  7. Onat A, Yüksel M, Köroğlu B, et al. Turkish Adult Risk Factor Study survey 2012: overall and coronary mortality and trends in the prevalence of metabolic syndrome. Turk Kardiyol Dern Ars 2013;41:373-8
  8. Procopio M, Barale M, Bertaina S, et al. Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine 2014;47:581-9
  9. Delfini E, Petramala L, Caliumi C. Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism 2007;56:30-6
  10. Luboshitzky R, Chertok-Schaham Y, Lavi I, Ishay A. Cardiovascular risk factors in primary hyperparathyroidism. J Endocrinol Invest 2009;32:317-21
  11. Rojas R, Aguilar-Salinas CA, Jiménez-Corona A, et al. Metabolic syndrome in Mexican adults: result from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010;52(Suppl 1):S11-8
  12. Ayturk S, Gursoy A, Bascil Tutuncu N, Ertugrul DT, Guvener Demirag N. Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 2006;91:4260-3
  13. Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S. Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 1988;297:960-3. g C, Lind L, Hellman P. Correlation between plasma calcium, parat